Shares of Gilead Sciences (GILD) ended an eventful week unchanged. The company announced a stock split and the acquisition of YM BioSciences in a matter of days.
Shareholder Returns
On Monday, Gilead Sciences announced that its Board of Directors have announced a two-for-one stock split. Stockholders of record on the 7th of January of 2013 will be entitled to another share. Shares of the company will be trading at their post-split price on January, 28th. As a result of the split, the number of shares outstanding will increase from 759.3 million to almost 1.52 billion shares.
No comments:
Post a Comment